Increased levels of DHFR compromise the antileukemic activity of MTX in childhood ALL, while higher intracellular levels of MTX with long glutamate chains, correlated with higher FPGS activity, are associated with improved survival in ALL patients [56,57]. The gene discussed is DHFR; the disease is acute lymphoblastic leukemia.